Total Payments
$9,096
2024 Payments
$3,142
Companies
27
Transactions
375
Medicare Patients
968
Medicare Billing
$103,075
Payment Breakdown by Category
Food & Beverage$8,805 (96.8%)
Consulting$262.50 (2.9%)
Other$14.48 (0.2%)
Education$13.89 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,805 | 372 | 96.8% |
| Consulting Fee | $262.50 | 1 | 2.9% |
| Entertainment | $14.48 | 1 | 0.2% |
| Education | $13.89 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,115 | 40 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,051 | 43 | $0 (2024) |
| Abbott Laboratories | $965.51 | 17 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $752.99 | 41 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $705.12 | 22 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $583.36 | 29 | $0 (2024) |
| PFIZER INC. | $544.54 | 29 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $504.31 | 28 | $0 (2024) |
| Novo Nordisk Inc | $500.51 | 26 | $0 (2024) |
| Daiichi Sankyo Inc. | $446.67 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,142 | 123 | Abbott Laboratories ($617.30) |
| 2023 | $2,740 | 120 | Merck Sharp & Dohme LLC ($359.70) |
| 2022 | $2,151 | 80 | E.R. Squibb & Sons, L.L.C. ($377.81) |
| 2021 | $1,063 | 52 | AstraZeneca Pharmaceuticals LP ($219.45) |
All Payment Transactions
375 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: Heart Failure | ||||||
| 12/17/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.61 | General |
| Category: Cardiovascular | ||||||
| 12/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: DIABETES | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $5.79 | General |
| Category: Cardiovascular | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: DIABETES | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.12 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $194.74 | General |
| Category: Heart Failure | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.69 | General |
| 11/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $31.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: DIABETES | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: DIABETES | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.82 | General |
| 10/08/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $104.18 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/07/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 90 | 97 | $10,115 | $6,517 |
| 2022 | 4 | 329 | 500 | $54,530 | $36,497 |
| 2021 | 4 | 303 | 474 | $53,510 | $36,490 |
| 2020 | 3 | 246 | 431 | $43,315 | $23,571 |
Total Patients
968
Total Services
1,502
Medicare Billing
$103,075
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 48 | 52 | $4,940 | $3,168 | 64.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 28 | 30 | $4,200 | $2,750 | 65.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 14 | 15 | $975.00 | $600.18 | 61.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 129 | 204 | $28,560 | $19,451 | 68.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 153 | 236 | $22,415 | $15,038 | 67.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 33 | 37 | $2,405 | $1,528 | 63.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2022 | 14 | 23 | $1,150 | $480.69 | 41.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 124 | 222 | $31,080 | $21,223 | 68.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 145 | 205 | $19,475 | $13,544 | 69.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 21 | 27 | $1,755 | $1,207 | 68.8% |
| 93750 | Evaluation of lower heart chamber assist device with physician analysis | Facility | 2021 | 13 | 20 | $1,200 | $515.00 | 42.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 154 | 315 | $29,925 | $16,464 | 55.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 57 | 78 | $10,920 | $5,806 | 53.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 35 | 38 | $2,470 | $1,302 | 52.7% |
About Blen Daniel, FNP
Blen Daniel, FNP is a Family healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2019. The National Provider Identifier (NPI) number assigned to this provider is 1285286492.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Blen Daniel, FNP has received a total of $9,096 in payments from pharmaceutical and medical device companies, with $3,142 received in 2024. These payments were reported across 375 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($8,805).
As a Medicare-enrolled provider, Daniel has provided services to 968 Medicare beneficiaries, totaling 1,502 services with total Medicare billing of $103,075. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Plano, TX
- Active Since 07/09/2019
- Last Updated 05/27/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1285286492
Products in Payments
- VERQUVO (Drug) $1,051
- CARDIOMEMS (Device) $852.83
- CAMZYOS (Drug) $718.21
- LifeVest (Device) $705.12
- JARDIANCE (Drug) $566.29
- INJECTAFER (Drug) $446.67
- ONPATTRO (Drug) $445.66
- VYNDAQEL (Drug) $432.74
- ENTRESTO (Drug) $422.92
- WAINUA (Drug) $345.09
- FARXIGA (Drug) $333.52
- Rybelsus (Drug) $284.81
- BRILINTA (Drug) $243.26
- Ozempic (Drug) $215.70
- Adempas (Drug) $163.92
- SAPIEN 3 Ultra RESILIA (Device) $131.16
- WatchPAT (Device) $113.31
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $112.68
- ELIQUIS (Drug) $111.80
- remede System (Device) $109.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Plano
Kori Nelson, Fnp-C, FNP-C
Family — Payments: $107,146
Family $107,146
Abiola Amure, Fnp-C, FNP-C
Family — Payments: $14,511
Family $14,511
Vicki Redpath
Family — Payments: $10,534
Family $10,534
Katelynn Mann, Msn, Fnp, MSN, FNP
Family — Payments: $10,231
Family $10,231
Ronnie Terry, Aprn, Rnfa, APRN, RNFA
Family — Payments: $8,895
Family $8,895
Maria Timis, Fnp-C, FNP-C
Family — Payments: $8,785
Family $8,785